HK1169832A1 - Novel solid materials of [2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)- 8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza- cyclopentadec-2-yl]-acetic acid and methods for obtaining them [(2s5r8s11s)-5--11-(3--)-8--7--36912 15--1471013---2-]- - Google Patents

Novel solid materials of [2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)- 8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza- cyclopentadec-2-yl]-acetic acid and methods for obtaining them [(2s5r8s11s)-5--11-(3--)-8--7--36912 15--1471013---2-]-

Info

Publication number
HK1169832A1
HK1169832A1 HK12110571.2A HK12110571A HK1169832A1 HK 1169832 A1 HK1169832 A1 HK 1169832A1 HK 12110571 A HK12110571 A HK 12110571A HK 1169832 A1 HK1169832 A1 HK 1169832A1
Authority
HK
Hong Kong
Prior art keywords
2s5r8s11s
cyclopentadec
pentaoxo
pentaaza
guanidino
Prior art date
Application number
HK12110571.2A
Other languages
English (en)
Chinese (zh)
Inventor
Alfred Jonczyk
Clemens Kuehn
Kerstin Seemann
Christoph Saal
Gerald Scholz
Soenke Petersen
Harald Untenecker
Michael Lange
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1169832A1 publication Critical patent/HK1169832A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
HK12110571.2A 2009-05-20 2012-10-24 Novel solid materials of [2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)- 8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza- cyclopentadec-2-yl]-acetic acid and methods for obtaining them [(2s5r8s11s)-5--11-(3--)-8--7--36912 15--1471013---2-]- HK1169832A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09006790 2009-05-20
PCT/EP2010/003100 WO2010133367A2 (en) 2009-05-20 2010-05-20 Novel solid materials of {[2s, 5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them

Publications (1)

Publication Number Publication Date
HK1169832A1 true HK1169832A1 (en) 2013-02-08

Family

ID=41338466

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12110571.2A HK1169832A1 (en) 2009-05-20 2012-10-24 Novel solid materials of [2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)- 8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza- cyclopentadec-2-yl]-acetic acid and methods for obtaining them [(2s5r8s11s)-5--11-(3--)-8--7--36912 15--1471013---2-]-

Country Status (14)

Country Link
US (2) US8586545B2 (xx)
EP (2) EP3085704A1 (xx)
JP (1) JP5878864B2 (xx)
KR (1) KR20120060947A (xx)
CN (1) CN102428098B (xx)
AU (1) AU2010251385B2 (xx)
BR (1) BRPI1012789A2 (xx)
CA (1) CA2762652C (xx)
EA (1) EA022831B1 (xx)
ES (1) ES2578026T3 (xx)
HK (1) HK1169832A1 (xx)
MX (1) MX2011012231A (xx)
WO (1) WO2010133367A2 (xx)
ZA (1) ZA201109327B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102223915A (zh) * 2008-11-20 2011-10-19 默克专利有限公司 应用整联蛋白配体治疗癌症的新疗法和药物
CN102652015B (zh) * 2009-12-10 2016-08-03 默克专利有限公司 包含寡肽、优选西仑吉肽的药物组合物
CN103717205B (zh) * 2011-06-09 2017-04-12 默克专利股份公司 用西仑吉肽在载体中的悬浮液治疗癌症和癌症转移

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534177A1 (de) 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
WO1998057648A1 (en) * 1997-06-16 1998-12-23 Vertex Pharmaceuticals Incorporated Methods of increasing the bioavailability of stable crystal polymorphs of a compound
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
CN102652015B (zh) * 2009-12-10 2016-08-03 默克专利有限公司 包含寡肽、优选西仑吉肽的药物组合物

Also Published As

Publication number Publication date
WO2010133367A2 (en) 2010-11-25
KR20120060947A (ko) 2012-06-12
CA2762652A1 (en) 2010-11-25
ES2578026T3 (es) 2016-07-20
US8765684B2 (en) 2014-07-01
US20140088022A1 (en) 2014-03-27
JP5878864B2 (ja) 2016-03-08
ZA201109327B (en) 2012-08-29
JP2012527417A (ja) 2012-11-08
WO2010133367A3 (en) 2011-10-27
EA201101638A1 (ru) 2012-06-29
EP3085704A1 (en) 2016-10-26
AU2010251385B2 (en) 2016-04-14
US20120065142A1 (en) 2012-03-15
US8586545B2 (en) 2013-11-19
AU2010251385A8 (en) 2012-02-16
CN102428098A (zh) 2012-04-25
BRPI1012789A2 (pt) 2018-01-16
EP2432801B1 (en) 2016-03-23
CN102428098B (zh) 2014-11-05
EP2432801A2 (en) 2012-03-28
CA2762652C (en) 2018-10-02
MX2011012231A (es) 2011-12-08
EA022831B1 (ru) 2016-03-31
AU2010251385A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
HK1181799A1 (en) Microporous material
ZA201202504B (en) Process for the preparation of calcobutrol
EP2497623A4 (en) Jig for manufacture of composite material structure
IL216935A0 (en) Process for the preparation of nacre mechano-structured by mechanosynthesis, mechano-structured nacre thus obtained and uses thereof
ZA201205103B (en) Pharmaceutical composition comprising oligopeptides,preferably cilengitide
SI2151428T1 (sl) Postopek za pripravo agomelatina
GB2466792B (en) Improved composite materials
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
EP2404780A4 (en) Structural material
IL219156A0 (en) Process for the preparation of f-series prostaglandins
IL225922A (en) Processes for Preparation of 3 - ((Pyrol-2-Yl) Methylene) -2-Pyrolons by Using 2-Silyloxy-Pyrolines
EP2344468A4 (en) PROCESS FOR PREPARING RAMELTÉON
GB201002082D0 (en) Biological material
PT2151429E (pt) Novo processo de síntese da agomelatina
HK1169832A1 (en) Novel solid materials of [2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)- 8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza- cyclopentadec-2-yl]-acetic acid and methods for obtaining them [(2s5r8s11s)-5--11-(3--)-8--7--36912 15--1471013---2-]-
EG26332A (en) Process for the preparation of benzonoprons
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
TWI367205B (en) Preparation of paricalcitol
IL215022A0 (en) Novel process for the preparation of enaminocarbonyl compounds
PL388885A1 (pl) Sposób wytwarzania nawozu organicznego
SI2387557T1 (sl) Postopek za pripravo N-(5-(3-dimetilamino-akriloil)-2-fluorofenil)-N-metil-acetamida
PL2356073T3 (pl) Sposób wytwarzania etanodinitrylu
IL220160A (en) A process for the preparation of defrasirox
AU2010902509A0 (en) Membrane Material
AU2010901022A0 (en) Membrane Material

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210524